Hongbo Zhang
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 41
- Electrospun Nanofibers in Biomedical Applications 24
- Biomedical Engineering top 0.1%
- Nanoplatforms for cancer theranostics 64
- 3D Printing in Biomedical Research 30
- Graphene and Nanomaterials Applications 21
- Pharmaceutical Science top 0.5%
- Cancer Research top 0.5%
- Rehabilitation top 0.5%
- Wound Healing and Treatments 16
-
- Advanced biosensing and bioanalysis techniques 45
- RNA Interference and Gene Delivery 38
- Co-authors
- Hélder A. SantosWenguo CuiJouni HirvonenErmei MäkiläJarno SalonenDongfei LiuLianfu DengJiaqi Yan
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Advanced Materials (24 papers)
- Partner nations
- ChinaFinlandUnited States
In The Last Decade
Hongbo Zhang
484 papers receiving 18.2k citations
Hit Papers
Peers
Comparison fields: 5 of 194
- Biomaterials 3.6k
- Biomedical Engineering 7.1k
- Pharmaceutical Science 738
- Cancer Research 1.7k
- Rehabilitation 763
Countries citing papers authored by Hongbo Zhang
This map shows the geographic impact of Hongbo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Zhang more than expected).
Fields of papers citing papers by Hongbo Zhang
This network shows the impact of papers produced by Hongbo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Zhang. The network helps show where Hongbo Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbo Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 16 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 45 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 15 | |
| 13 | 2023 | 2 | |
| 14 | Mimicking Antioxidases and Hyaluronan Synthase: A Zwitterionic Nanozyme for Photothermal Therapy of Osteoarthritisbreakdown → | 2023 | 100 |
| 15 | 2022 | 32 | |
| 16 | 2022 | 18 | |
| 17 | 2021 | 23 | |
| 18 | 2020 | 40 | |
| 19 | 2019 | 44 | |
| 20 | 2018 | 187 |
About Hongbo Zhang
Hongbo Zhang is a scholar working on Biomaterials, Biomedical Engineering and Microbiology, having authored 507 papers that have together received 18.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (64 papers), Advanced biosensing and bioanalysis techniques (45 papers), Nanoparticle-Based Drug Delivery (41 papers), RNA Interference and Gene Delivery (38 papers), 3D Printing in Biomedical Research (30 papers), Electrospun Nanofibers in Biomedical Applications (24 papers), Graphene and Nanomaterials Applications (21 papers) and Wound Healing and Treatments (16 papers). The work is most often cited by research in Biomaterials (3.6k citations), Biomedical Engineering (7.1k citations) and Pharmaceutical Science (738 citations). Hongbo Zhang has collaborated with scholars based in China, Finland and United States. Frequent co-authors include Hélder A. Santos, Wenguo Cui, Jouni Hirvonen, Ermei Mäkilä, Jarno Salonen, Dongfei Liu, Lianfu Deng, Jiaqi Yan, Flavia Fontana and Xiangmeng Qu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.